Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04769453 · ClinicalTrials.gov registry record · NA
Multicenter Ab-interno Glaucoma Study Investigating Canaloplasty
A NA study, sponsored by Nova Eye.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04769453 is a NA study that was terminated before completion, run by Nova Eye. The registered enrollment target is 20 participants.
The verdict
NCT04769453, a NA study, was terminated before completion, sponsored by Nova Eye.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
A prospective, multicenter, randomized, single-masked clinical trial to evaluate the effectiveness outcomes of canaloplasty performed as a standalone procedure with the iTrack microcatheter to the Omni surgical system, and to compare the effectiveness of two types of Ophthalmic Viscoelastic Device (OVD).
Interventions
- DEVICE Canaloplasty using the iTrack microcatheter with Healon GV Pro
- DEVICE Canaloplasty using the Omni surgical system with Healon GV Pro
- DEVICE Canaloplasty using the iTrack microcatheter with Healon Pro
- DEVICE Canaloplasty using the Omni surgical system with Healon Pro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-04-29 |
| Est. Completion | 2023-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04769453
The ClinicalTrials.gov registry entry for NCT04769453 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nova Eye, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Canaloplasty using the iTrack microcatheter with Healon GV Pro is the first listed.
NCT04769453 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04769453 about?
NCT04769453 is a clinical study titled "Multicenter Ab-interno Glaucoma Study Investigating Canaloplasty". A prospective, multicenter, randomized, single-masked clinical trial to evaluate the effectiveness outcomes of canaloplasty performed as a standalone procedure with the iTrack microcatheter to the Omni surgical system, and to compare the effectiveness of two types of Ophthalmic Viscoelastic Device (...
What is the current status of trial NCT04769453?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2021-04-29. Estimated completion is 2023-01-26.
What interventions are being tested in trial NCT04769453?
The interventions under investigation include: Canaloplasty using the iTrack microcatheter with Healon GV Pro (DEVICE), Canaloplasty using the Omni surgical system with Healon GV Pro (DEVICE), Canaloplasty using the iTrack microcatheter with Healon Pro (DEVICE), Canaloplasty using the Omni surgical system with Healon Pro (DEVICE).
Who is sponsoring clinical trial NCT04769453?
This trial is sponsored by Nova Eye, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.